Scheinberg DA - Search Results

1

Cytoreduction with iodine-131-anti-CD33 antibodies before bone marrow transplantation for advanced myeloid leukemias.

Burke JM, Caron PC, Papadopoulos EB, Divgi CR, Sgouros G, Panageas KS, Finn RD, Larson SM, O'Reilly RJ, Scheinberg DA, Jurcic JG. Burke JM, et al. Among authors: scheinberg da. Bone Marrow Transplant. 2003 Sep;32(6):549-56. doi: 10.1038/sj.bmt.1704201. Bone Marrow Transplant. 2003. PMID: 12953125 Clinical Trial.

2

Engineered humanized dimeric forms of IgG are more effective antibodies.

Caron PC, Laird W, Co MS, Avdalovic NM, Queen C, Scheinberg DA. Caron PC, et al. Among authors: scheinberg da. J Exp Med. 1992 Oct 1;176(4):1191-5. doi: 10.1084/jem.176.4.1191. J Exp Med. 1992. PMID: 1402660 Free PMC article.

3

Biological and immunological features of humanized M195 (anti-CD33) monoclonal antibodies.

Caron PC, Co MS, Bull MK, Avdalovic NM, Queen C, Scheinberg DA. Caron PC, et al. Among authors: scheinberg da. Cancer Res. 1992 Dec 15;52(24):6761-7. Cancer Res. 1992. PMID: 1458463

4

Chimeric and humanized antibodies with specificity for the CD33 antigen.

Co MS, Avdalovic NM, Caron PC, Avdalovic MV, Scheinberg DA, Queen C. Co MS, et al. Among authors: scheinberg da. J Immunol. 1992 Feb 15;148(4):1149-54. J Immunol. 1992. PMID: 1737932

5

A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclide.

Scheinberg DA, Lovett D, Divgi CR, Graham MC, Berman E, Pentlow K, Feirt N, Finn RD, Clarkson BD, Gee TS, et al. Scheinberg DA, et al. J Clin Oncol. 1991 Mar;9(3):478-90. doi: 10.1200/JCO.1991.9.3.478. J Clin Oncol. 1991. PMID: 1999719 Clinical Trial.

6

Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid-specific monoclonal antibodies and drugs in combination.

Lemoli RM, Gasparetto C, Scheinberg DA, Moore MA, Clarkson BD, Gulati SC. Lemoli RM, et al. Among authors: scheinberg da. Blood. 1991 Apr 15;77(8):1829-36. Blood. 1991. PMID: 2015406 Free article. Clinical Trial.

7

A phase I toxicity, pharmacology, and dosimetry trial of monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma: effects of tumor burden and antigen expression.

Scheinberg DA, Straus DJ, Yeh SD, Divgi C, Garin-Chesa P, Graham M, Pentlow K, Coit D, Oettgen HF, Old LJ. Scheinberg DA, et al. J Clin Oncol. 1990 May;8(5):792-803. doi: 10.1200/JCO.1990.8.5.792. J Clin Oncol. 1990. PMID: 2332769

8

Restricted expression of an early myeloid and monocytic cell surface antigen defined by monoclonal antibody M195.

Tanimoto M, Scheinberg DA, Cordon-Cardo C, Huie D, Clarkson BD, Old LJ. Tanimoto M, et al. Among authors: scheinberg da. Leukemia. 1989 May;3(5):339-48. Leukemia. 1989. PMID: 2716349

9

Monoclonal antibody therapy of leukemia and lymphoma.

Jurcic JG, Caron PC, Scheinberg DA. Jurcic JG, et al. Among authors: scheinberg da. Adv Pharmacol. 1995;33:287-314. doi: 10.1016/s1054-3589(08)60672-9. Adv Pharmacol. 1995. PMID: 7495673 Review. No abstract available.

10

Impact of the high tyrosine fraction in complementarity determining regions: measured and predicted effects of radioiodination on IgG immunoreactivity.

Nikula TK, Bocchia M, Curcio MJ, Sgouros G, Ma Y, Finn RD, Scheinberg DA. Nikula TK, et al. Among authors: scheinberg da. Mol Immunol. 1995 Aug;32(12):865-72. doi: 10.1016/0161-5890(95)00052-g. Mol Immunol. 1995. PMID: 7565813

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

299 results

Search Page

Filters